{
    "2018-01-19": [
        [
            {
                "time": "2018-01-19",
                "original_text": "复星医药(02196)经总裁提名 聘任李东明为公司副总裁",
                "features": {
                    "keywords": [
                        "复星医药",
                        "总裁提名",
                        "副总裁"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-01-19",
                "original_text": "上海医药折让近7%配股 现跌5%",
                "features": {
                    "keywords": [
                        "上海医药",
                        "配股",
                        "折让",
                        "股价下跌"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-01-19",
                "original_text": "港股开盘（1.19）︱恒指高开0.06%报32142点 次新股希玛眼科(03309)高开近12%",
                "features": {
                    "keywords": [
                        "恒指",
                        "高开",
                        "希玛眼科",
                        "次新股"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "综合"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-19",
                "original_text": "[港股] 上海医药拟折让6.7%配售1.53亿股H股",
                "features": {
                    "keywords": [
                        "上海医药",
                        "配售",
                        "H股",
                        "折让"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-01-19",
                "original_text": "上海医药增发1.5亿股H股",
                "features": {
                    "keywords": [
                        "上海医药",
                        "增发",
                        "H股"
                    ],
                    "sentiment_score": 0.0,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-01-19",
                "original_text": "66药企两票制资质申报被退回！上药、云南白药、GSK……",
                "features": {
                    "keywords": [
                        "两票制",
                        "资质申报",
                        "上药",
                        "云南白药",
                        "GSK"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-01-19",
                "original_text": "上海医药(02607)拟折让6.71%配售1.53亿股",
                "features": {
                    "keywords": [
                        "上海医药",
                        "配售",
                        "折让"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-01-19",
                "original_text": "早间公告：金河生物获实控人增持",
                "features": {
                    "keywords": [
                        "金河生物",
                        "实控人",
                        "增持"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-19",
                "original_text": "早间公告：金河生物获实控人增持；上海医药拟配股募资31亿港元",
                "features": {
                    "keywords": [
                        "金河生物",
                        "实控人",
                        "增持",
                        "上海医药",
                        "配股",
                        "募资"
                    ],
                    "sentiment_score": 0.2,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}